» Articles » PMID: 15679866

Effect of Stem Cell Mobilization with Cyclophosphamide Plus Granulocyte Colony-stimulating Factor on Morphology of Haematopoietic Organs in Mice

Overview
Journal Cell Prolif
Date 2005 Feb 1
PMID 15679866
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Both granulocyte colony-stimulating factor (G-CSF) and cyclophosphamide (CY) are employed in the clinic as mobilizing agents to stimulate the egress of haematopoietic stem/progenitor cells (HSPC) from bone marrow (BM) into peripheral blood (PB). However, although both compounds are effective, the simultaneous administration of G-CSF + CY allows for optimal mobilization. The aim of this study was to compare morphological changes in major haematopoietic organs in mice mobilized by G-CSF + CY. We employed the standard G-CSF + CY mobilization protocol, in which mice were injected at day 0 with a single dose of CY followed by daily injection of G-CSF for 6 consecutive days. We noticed that the cytoreductive effect of CY on BM and spleen tissue was compensated at day 2 by the pro-proliferative effect of G-CSF. Furthermore, as evidenced by histological examination of BM sections at day 4, egress of haematopoietic cells from BM was accelerated by 2 days as compared to mobilization by G-CSF or CY alone; also, by day 6 there was accumulation of early haematopoietic (Thy-l(low) c-kit+) cells in the spleens and livers of mobilized animals. This implies that HSPC that are mobilized from BM and circulate in PB may 'home' to peripheral organs. We envision that such an accumulation of these cells in the spleen (which is a major haematopoietic organ in mouse) allows them to participate in haematopoietic reconstitution. Their homing to other sites (for example the liver) is evidence that BM-derived stem cells are playing a pivotal role in organ/tissue regeneration. The potential involvement of major chemoattractants for stem cells, like stromal-derived factor-1 which is induced by CY in various regenerating organs such as the liver, requires further study. We conclude that inclusion of CY into mobilization protocols on the one hand efficiently increases the egress of HSPC from the BM, but on the other hand may lead to the relocation of BM stem cell pools to peripheral tissues.

Citing Articles

Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells.

Omer-Javed A, Pedrazzani G, Albano L, Ghaus S, Latroche C, Manzi M Cell. 2022; 185(13):2248-2264.e21.

PMID: 35617958 PMC: 9240327. DOI: 10.1016/j.cell.2022.04.039.


[Effect of cyclophosphamide on hematopoietic stem cells in mice with iron overload].

Xu Y, Yi T, Xu X, Pei F, He Y, Wu X Nan Fang Yi Ke Da Xue Xue Bao. 2020; 40(1):110-117.

PMID: 32376555 PMC: 7040758. DOI: 10.12122/j.issn.1673-4254.2020.01.18.


Pretreatment with G-CSF Could Enhance the Antifibrotic Effect of BM-MSCs on Pulmonary Fibrosis.

Zhao F, Liu W, Yue S, Yang L, Hua Q, Zhou Y Stem Cells Int. 2019; 2019:1726743.

PMID: 30719047 PMC: 6335774. DOI: 10.1155/2019/1726743.


Current Developments in Mobilization of Hematopoietic Stem and Progenitor Cells and Their Interaction with Niches in Bone Marrow.

Richter R, Forssmann W, Henschler R Transfus Med Hemother. 2017; 44(3):151-164.

PMID: 28626366 PMC: 5473067. DOI: 10.1159/000477262.


Cellular players of hematopoietic stem cell mobilization in the bone marrow niche.

Tay J, Levesque J, Winkler I Int J Hematol. 2016; 105(2):129-140.

PMID: 27943116 DOI: 10.1007/s12185-016-2162-4.


References
1.
McQuibban G, Butler G, Gong J, Bendall L, Power C, Clark-Lewis I . Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem. 2001; 276(47):43503-8. DOI: 10.1074/jbc.M107736200. View

2.
Papayannopoulou T . Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization. Blood. 2003; 103(5):1580-5. DOI: 10.1182/blood-2003-05-1595. View

3.
Forbes S, Vig P, Poulsom R, Thomas H, Alison M . Hepatic stem cells. J Pathol. 2002; 197(4):510-8. DOI: 10.1002/path.1163. View

4.
Pojda Z, Molineux G, Dexter T . Hemopoietic effects of short-term in vivo treatment of mice with various doses of rhG-CSF. Exp Hematol. 1990; 18(1):27-31. View

5.
Sefc L, Psenak O, Sykora V, Sulc K, Necas E . Response of hematopoiesis to cyclophosphamide follows highly specific patterns in bone marrow and spleen. J Hematother Stem Cell Res. 2003; 12(1):47-61. DOI: 10.1089/152581603321210136. View